Ulthera filed for a U.S. initial public offering yesterday, saying it hopes to raise as much as $86 million when it debuts on the NASDAQ stock exchange.
Mesa, Ariz.-based Ulthera makes an ultrasound device, which is designed to use the body’s natural healing process to non-invasively lift and tighten loose skin on the neck and under the chin.
The Ulthera system combines ultrasound imaging with focused ultrasound therapy, representing the only energy-based device with an indication to "tighten turkey necks and smooth out double-chins," according to Ulthera.
The company won 510(k) clearance from the FDA for the device in October 2012.
Ulthera plans to trade under the "ULTH" symbol, according to a regulatory filing.
